BIOVENTIX PLC ORD GBP0.05 revenue for the last year amounted to 12.82 M GBP, the most of which — 12.82 M GBP — came from its highest performing source at the moment, Sheep Monoclonal Antibodies, the year earlier bringing 11.72 M GBP. The greatest contribution to the revenue figure was made by Rest of the World — last year it brought BIOVENTIX PLC ORD GBP0.05 10.25 M GBP, and the year before that — 9.60 M GBP.